These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 31735283)
1. BAP1 Missense Mutations in Cancer: Friend or Foe? Okonska A; Felley-Bosco E Trends Cancer; 2019 Nov; 5(11):659-662. PubMed ID: 31735283 [TBL] [Abstract][Full Text] [Related]
2. Familial and Somatic Peng H; Prokop J; Karar J; Park K; Cao L; Harbour JW; Bowcock AM; Malkowicz SB; Cheung M; Testa JR; Rauscher FJ Cancer Res; 2018 Mar; 78(5):1200-1213. PubMed ID: 29284740 [TBL] [Abstract][Full Text] [Related]
3. Autodeubiquitination protects the tumor suppressor BAP1 from cytoplasmic sequestration mediated by the atypical ubiquitin ligase UBE2O. Mashtalir N; Daou S; Barbour H; Sen NN; Gagnon J; Hammond-Martel I; Dar HH; Therrien M; Affar el B Mol Cell; 2014 May; 54(3):392-406. PubMed ID: 24703950 [TBL] [Abstract][Full Text] [Related]
4. Cancer associated missense mutations in BAP1 catalytic domain induce amyloidogenic aggregation: A new insight in enzymatic inactivation. Bhattacharya S; Hanpude P; Maiti TK Sci Rep; 2015 Dec; 5():18462. PubMed ID: 26680512 [TBL] [Abstract][Full Text] [Related]
5. Population-based analysis of BAP1 germline variations in patients with uveal melanoma. Repo P; Järvinen RS; Jäntti JE; Markkinen S; Täll M; Raivio V; Turunen JA; Kivelä TT Hum Mol Genet; 2019 Jul; 28(14):2415-2426. PubMed ID: 31058963 [TBL] [Abstract][Full Text] [Related]
6. Impacts of Cancer-associated Mutations on the Structure-Activity Relationship of BAP1. Puri S; Chen SN; Chiu YH; Draczkowski P; Ko KT; Yang TJ; Wang YS; Uchiyama S; Hsu SD J Mol Biol; 2022 May; 434(9):167553. PubMed ID: 35317997 [TBL] [Abstract][Full Text] [Related]
7. Roles of the BAP1 Tumor Suppressor in Cell Metabolism. Han A; Purwin TJ; Aplin AE Cancer Res; 2021 Jun; 81(11):2807-2814. PubMed ID: 33446574 [TBL] [Abstract][Full Text] [Related]
8. Ubiquitin recognition of BAP1: understanding its enzymatic function. Hanpude P; Bhattacharya S; Kumar Singh A; Kanti Maiti T Biosci Rep; 2017 Oct; 37(5):. PubMed ID: 28935764 [TBL] [Abstract][Full Text] [Related]
9. BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesothelioma. Shrestha R; Nabavi N; Lin YY; Mo F; Anderson S; Volik S; Adomat HH; Lin D; Xue H; Dong X; Shukin R; Bell RH; McConeghy B; Haegert A; Brahmbhatt S; Li E; Oo HZ; Hurtado-Coll A; Fazli L; Zhou J; McConnell Y; McCart A; Lowy A; Morin GB; Chen T; Daugaard M; Sahinalp SC; Hach F; Le Bihan S; Gleave ME; Wang Y; Churg A; Collins CC Genome Med; 2019 Feb; 11(1):8. PubMed ID: 30777124 [TBL] [Abstract][Full Text] [Related]
10. BAP1 germline mutation in two first grade family members with uveal melanoma. Maerker DA; Zeschnigk M; Nelles J; Lohmann DR; Worm K; Bosserhoff AK; Krupar R; Jägle H Br J Ophthalmol; 2014 Feb; 98(2):224-7. PubMed ID: 24187051 [TBL] [Abstract][Full Text] [Related]
12. Targeting BAP1: a new paradigm for mesothelioma. Schunselaar LM; Zwart W; Baas P Lung Cancer; 2017 Jul; 109():145-146. PubMed ID: 28342657 [TBL] [Abstract][Full Text] [Related]
13. Loss of the tumor suppressor BAP1 causes myeloid transformation. Dey A; Seshasayee D; Noubade R; French DM; Liu J; Chaurushiya MS; Kirkpatrick DS; Pham VC; Lill JR; Bakalarski CE; Wu J; Phu L; Katavolos P; LaFave LM; Abdel-Wahab O; Modrusan Z; Seshagiri S; Dong K; Lin Z; Balazs M; Suriben R; Newton K; Hymowitz S; Garcia-Manero G; Martin F; Levine RL; Dixit VM Science; 2012 Sep; 337(6101):1541-6. PubMed ID: 22878500 [TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma. Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874 [TBL] [Abstract][Full Text] [Related]
15. A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma. Wadt KA; Aoude LG; Johansson P; Solinas A; Pritchard A; Crainic O; Andersen MT; Kiilgaard JF; Heegaard S; Sunde L; Federspiel B; Madore J; Thompson JF; McCarthy SW; Goodwin A; Tsao H; Jönsson G; Busam K; Gupta R; Trent JM; Gerdes AM; Brown KM; Scolyer RA; Hayward NK Clin Genet; 2015 Sep; 88(3):267-72. PubMed ID: 25225168 [TBL] [Abstract][Full Text] [Related]
16. Germline mutations in BAP1 impair its function in DNA double-strand break repair. Ismail IH; Davidson R; Gagné JP; Xu ZZ; Poirier GG; Hendzel MJ Cancer Res; 2014 Aug; 74(16):4282-94. PubMed ID: 24894717 [TBL] [Abstract][Full Text] [Related]
17. Genomic profiling of the genes on chromosome 3p in sporadic clear cell renal cell carcinoma. Togo Y; Yoshikawa Y; Suzuki T; Nakano Y; Kanematsu A; Zozumi M; Nojima M; Hirota S; Yamamoto S; Hashimoto-Tamaoki T Int J Oncol; 2016 Apr; 48(4):1571-80. PubMed ID: 26891804 [TBL] [Abstract][Full Text] [Related]
18. Loss of nuclear BAP1 expression is associated with poor prognosis in oral mucosal melanoma. Song H; Wang L; Lyu J; Wu Y; Guo W; Ren G Oncotarget; 2017 Apr; 8(17):29080-29090. PubMed ID: 28404968 [TBL] [Abstract][Full Text] [Related]
19. Analysis of the exome aggregation consortium (ExAC) database suggests that the BAP1-tumor predisposition syndrome is underreported in cancer patients. Massengill JB; Sample KM; Pilarski R; McElroy J; Davidorf FH; Cebulla CM; Abdel-Rahman MH Genes Chromosomes Cancer; 2018 Sep; 57(9):478-481. PubMed ID: 29761599 [TBL] [Abstract][Full Text] [Related]
20. Research Progress of BAP1 in Structure, Function, and Cancer. Lu WT; Li MR; Yang YB; Sun YY; Dong CM Protein Pept Lett; 2023; 30(7):552-561. PubMed ID: 37246324 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]